Vineet Laboratories Ltd Share Price & Stock Analysis

Vineet Laboratories Ltd (NSE: VINEETLAB, BSE: 543298) is a Hyderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹72 Cr, it ranks #3,514 by market cap among the 6,197 Indian listed companies on FinBizNet, and #72 of 86 in Medicinal Chemicals and Botanical Products. At ₹37.75 (as of 16 Nov 2026), the share price is 16.5% below its 52-week high of ₹45.20 and 35.0% above its 52-week low of ₹27.96. The share price is down 15.3% over one year and down 1.7% over three months.

Key Metrics

Current Price₹37.75
Market Cap₹72 Cr
NSE SymbolVINEETLAB
BSE Code543298
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio38
Return on Equity3.68%
Return on Assets3.52%
52-Week Range₹27.96 – ₹45.20
1-Year Price Change-15.3%
3-Month Price Change-1.7%
Beta (1Y)0.22
Dividend Yield0.00%
HeadquartersHyderabad, Telangana
Websitevineetlabs.co.in

Latest Quarterly Results — Q2 FY27

Revenue₹14 Cr
Net Profit₹0 Cr
Net Margin0.8%
EPS (Basic)₹0.06
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Vineet Laboratories Ltd Quarterly Revenue and Profit Trend

Vineet Laboratories Ltd reported revenue of ₹14 Cr in Q2 FY27, down 18.6% from ₹17 Cr in Q2 FY26 and up 36.5% from ₹10 Cr in Q1 FY27. It posted a net profit of ₹0 Cr for the quarter, against a net profit of ₹0 Cr in Q2 FY26 (down 70.0%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹7 Cr (Q1 FY26) to ₹19 Cr (Q4 FY26). The company reported a net loss in 2 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹14 Cr₹0 Cr0.8%
Q1 FY27₹10 Cr₹2 Cr14.5%
Q4 FY26₹19 Cr₹1 Cr6.5%
Q3 FY26₹16 Cr₹1 Cr5.4%
Q2 FY26₹17 Cr₹0 Cr2.3%
Q1 FY26₹7 Cr−₹1 Cr−11.7%
Q4 FY25₹14 Cr−₹11 Cr−74.8%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 5.98% of Vineet Laboratories Ltd's shares as of Sept 2026, against 12.46% in Dec 2025 (−6.48 percentage points). Delivery averaged 70.6% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Vineet Laboratories Ltd

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.

Products and Services

1. Drug Intermediates & Bulk Dugs-This segment engages in the research, development, and manufacture of active pharmaceutical ingredients and fine chemicals.

Business Segments

1. Active Pharmaceuticals Ingredient and Intermediates-100%

Vineet Laboratories Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Vineet Laboratories Ltd₹72 Cr383.68%₹14 Cr-15.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Vineet Laboratories Ltd?

Vineet Laboratories Ltd is trading at ₹37.75, with a market capitalisation of ₹72 Cr.

Which sector does Vineet Laboratories Ltd belong to?

Vineet Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Vineet Laboratories Ltd?

Vineet Laboratories Ltd has a P/E of 38 and a return on equity of 3.68%.

What is the stock symbol of Vineet Laboratories Ltd?

Vineet Laboratories Ltd is listed on the NSE under the symbol VINEETLAB and on the BSE under the scrip code 543298.

How has Vineet Laboratories Ltd's share price moved over the past year?

Vineet Laboratories Ltd's share price is down 15.3% over one year and down 1.7% over three months. Its 52-week range is ₹27.96 to ₹45.20.

What were Vineet Laboratories Ltd's latest quarterly results?

In Q2 FY27, Vineet Laboratories Ltd reported revenue of ₹14 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.06 (standalone, parsed from the company's exchange filing).

How have Vineet Laboratories Ltd's revenue and profit changed over the past year?

Vineet Laboratories Ltd reported revenue of ₹14 Cr in Q2 FY27, down 18.6% from ₹17 Cr in Q2 FY26 and up 36.5% from ₹10 Cr in Q1 FY27.

What is the promoter holding in Vineet Laboratories Ltd?

Promoters held 5.98% of Vineet Laboratories Ltd's shares as of Sept 2026, against 12.46% in Dec 2025 (−6.48 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.